FDA Inspection
Avadim Holdings IncAvadim Holdings Inc – FDA Inspection, Mar 31, 2009
Record Details
This FDA Inspection record concerns Avadim Holdings Inc, with an inspection on March 31, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Avadim Holdings Inc
- Inspection Date
- March 31, 2009
- Product Type
- Drugs
View Company Profile
ID · 3cafed9d-7607-4b76-8264-9e585513a313
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 580182
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.166(a)Lack of written stability program
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Avadim Holdings Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 22, 2025 | OAI | Atlanta District Office | Drug Quality Assurance |
| March 6, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 4, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Avadim Holdings Inc
- FDA Inspection 1270610 - 2025-05-22
- FDA Inspection 1084850 - 2019-03-06
- FDA Inspection 993645 - 2016-11-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.